See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2019_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 82,492,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,793,000 |
| 3 | remainder_Assets | 5,547,000 |
| 4 | LiabilitiesCurrent | 23,055,000 |
| 5 | LiabilitiesNoncurrent | 13,838,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 879,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,139,943 |
| 9 | ResearchAndDevelopmentExpense | 38,114,273 |
| 10 | remainder_Expenses | 594,868 |
| 11 | remainder_Revenues | 25,881,090 |
| 12 | remainder_NetIncome | 3,779,971 |
| 13 | remainder_ComprehensiveNetIncome | -4,236,903 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 89,832,000 |
| 1 | Liabilities | 36,893,000 |
| 2 | Expenses | 54,728,084 |
| 3 | Revenues | 25,881,090 |
| 4 | StockholdersEquity | 52,939,000 |
| 5 | NetIncome | -25,067,023 |
| 6 | ComprehensiveNetIncome | -27,185,474 |
| 7 | BaseVar | 107,675,524 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.39 |
| 9 | EconomicCapitalRatio | 2.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
